Discover 815 paid clinical trials in Jacksonville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Jacksonville currently offers many active clinical trials, particularly in the areas of diabetes, cardiovascular health, and chronic pain management. With opportunities for both healthy volunteers seeking paid studies, as well as those looking for trials tailored to specific conditions, these trials offer participants access to cutting-edge treatments while advancing healthcare.
Filter
2
Filter results
Results: 815
New
Ocular Dysbiosis in Eyelid Disease
for
Anterior Blepharitis
Location: Jacksonville FL, Mint Hill NC, Shelby NC, Pittsburg KS,
Sponsor: Brent Kramer
Sex: All
Age: 18+
Code: NCT07869498
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Jacksonville FL, Tampa FL, Atlanta GA, Birmingham AL,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase2, Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: Jacksonville FL, Atlanta GA, Birmingham AL,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
for
Multiple Myeloma
Location: Jacksonville FL, Encinitas CA, Alhambra CA,
Sponsor: Oncotherapeutics
Sex: All
Age: 18+
Code: NCT03110822
Phase1, Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Jacksonville FL, Atlanta GA, Myrtle Beach SC,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Location: Jacksonville FL, Sarasota FL, Fort Myers FL,
Sponsor: Artios Pharma Ltd
Sex: All
Age: 18+
Code: NCT04657068
Phase1, Phase2, Recruiting
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
for
Extensive-stage Small-cell Lung Cancer
Location: Jacksonville FL, Atlanta GA, Rock Hill SC, Lexington KY,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07459634
Phase2, Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Location: Jacksonville FL, Mobile AL, New York NY, Coon Rapids MN
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218341
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Jacksonville FL, Ocala FL, Orange City FL, Tampa FL,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Jacksonville FL, Charleston SC, Miami FL, Charlotte NC,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase3, Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Jacksonville FL, Valdosta GA, Palm Bay FL,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation